Cardiovascular disease is becoming more manageable—and preventable. Important progress has included the American College of Cardiology (ACC) 2016 Expert Consensus Decision Pathway on the management of cholesterol, the National Lipid Association (NLA) 2017 recommendations that frame the use of the two approved PCSK9 inhibitors.
Take this 5-question Quick Quiz to assess your knowledge on the role of PCSK9 inhibitors in cardiovascular risk reduction. The quiz is intended to provide pharmacists with professional guidance regarding the identification of patients that would benefit from this type of treatment.
At the completion of this knowledge-based activity, pharmacists will be able to:
- Identify patients who may be appropriate for treatment with PCSK9 inhibitors.
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Number for this activity is 0202-0000-17-242-H01-P.
To claim 0.5 contact hours of CPE credit (0.1 CEU) for participating in this online learning activity, APhA Quick Quiz: PCSK9 Inhibitors, participants will need to complete all 5 questions provided, answer the evaluation questions, then CLAIM credit. A valid pharmacist.com username and password is required to claim credit. After credit has been claimed, please visit CPE monitor for CPE transcript.
Initial release date: October 18, 2017
Expiration date: October 18, 2020 - NO CREDIT GRANTED AFTER THIS DATE
Activity Type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 2
"APhA Quick Quiz: PCSK9 Inhibitors" is an online continuing education activity for pharmacists developed by the American Pharmacists Association.
Joseph Saseen, PharmD, BCPS, BCACP, and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, please visit the APhA website at: www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, PharmD, BCACP, Associate Director of Content Development at the American Pharmacists Association.
Computer and internet access are required to complete this activity. Please visit our website to view the System Requirements in order to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-17-242-H01-P||0.05 CEUs||October 18, 2017 - October 18, 2020|